High-fat diet mouse model receiving L-glucose supplementations propagates liver injury von Amer, Johnny, Amleh, Athar, Salhab, Ahmad, Kolodny, Yuval, Yochelis, Shira, Saffouri, Baker, Paltiel, Yossi, Safadi, Rifaat

Volltext

Novel natural killer cell immunotherapy through synthesized Neuroligin-4 peptides improved liver fibrosis von Saffouri, Baker, Amer, Johnny, Salhab, Ahmad, Safadi, Rifaat

Volltext

WED-226 - Novel natural killer cell immunotherapy through synthesized Neuroligin-4 peptides improved liver fibrosis von Saffouri, Baker, Amer, Johnny, Salhab, Ahmad, Safadi, Rifaat

Volltext

LBP-035 Luji-1 reduces fibrosis by blocking Neuroligin-4 and β-neurexin and overexpressing thyroid hormone receptor-b, suggesting Rezdiffra sensitization and synergism in combinati... von Amer, Johnny, Salhab, Ahmad, Saffouri, Baker, Imam, Ashraf, Khalaileh, Abed, Safadi, Rifaat

Volltext

PWE-045 Vedolizumab results in reduced hospitalisation and steroid use over 1-year:results from the scottish vedolizumab cohort von Plevris, Nikolas, Chuah, Cher, Jenkinson, Phil, Allen, R, Baker, P, Brennan, Paul, Churchhouse, Antonia, Din, S, Donoghue, Emma, Gaya, Daniel, Groome, Max, Jafferbhoy, H, Jones, G, Macdonald, Jonathan, MacMaster, Morag, Mowat, Craig, Naismith, G, Noble, C, Potts, L, Saffouri, E, Seenan, JP, Sengupta, A, Shand, Alan, Shasi, P, Todd, J, Veryan, J, Watson, A, Watson, E, Watts, D, Arnott, I, Lees, C

Volltext

P399 Vedolizumab therapy results in reduced hospitalisation and steroid use over 1-year: Results from the Scottish vedolizumab consortium von Plevris, N, Chuah, C S, Allen, R, Baker, P, Brennan, P, Churchhouse, A, Donoghue, E, Gaya, D, Jafferbhoy, H, Jenkinson, P, Jones, G, Macdonald, J, MacMaster, M, Mowat, C, Naismith, G, Potts, L, Saffouri, E, Seenan, J P, Sengupta, A, Shasi, P, Todd, J, Veryan, J, Watson, A, Watts, D, Arnott, I, Lees, C, Groome, M

Volltext